San Diego, CA, United States of America

Alexander R Rovira

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander R Rovira. Retrieved from https://idiyas.com/inventor/alexander-r-rovira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander R Rovira - Innovator in Pharmaceutical Research

Introduction

Alexander R Rovira is a notable inventor based in San Diego, CA. He is currently associated with Janssen Pharmaceutica NV, where he contributes to the field of pharmaceutical research. Although he has not yet been granted any patents, his work is focused on developing innovative compounds that have the potential to address significant health challenges.

Latest Patent Applications

Alexander R Rovira has been involved in several recent patent applications. One of his latest applications is titled "Pyrrolidione Derivatives as Inhibitors of NF Kappa B Inducing Kinase." This application discusses compounds of Formula (I) that inhibit NIK and pharmaceutical compositions comprising such compounds. These compounds and compositions are aimed at preventing or treating diseases, including inflammatory and autoimmune disorders. Another application is titled "Pyrrolidinone Derivatives as Inhibitors of NF Kappa B Inducing Kinase." Similar to the previous application, it relates to compounds of Formula (I′) that inhibit NIK and their potential therapeutic uses.

Conclusion

Alexander R Rovira is making strides in pharmaceutical innovation, focusing on compounds that could significantly impact the treatment of various diseases. His ongoing research and patent applications reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…